Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe.

BMC medical genomics - 19 Jun 2017

Lu Mengfei, Lewis Cathryn M, Traylor Matthew

Abstract excerpt

BACKGROUND: Rapid advances in scientific research have led to an increase in public awareness of genetic testing and pharmacogenetics. Direct-to-consumer (DTC) genetic testing companies, such as 23andMe, allow consumers to access their genetic information directly through an online service without the involvement of healthcare professionals. Here, we evaluate the clinical relevance of pharmacogenetic tests...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Pharmacogenomic Testing
Share to Polymorphism, Single Nucleotide
Share to United Kingdom

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Open in PubMed Open full text

Identifiers

PMID: 28629370
DOI: 10.1186/s12920-017-0283-0
PMCID: PMC5477417

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe.PMID 28629370Read ↗

Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMeSemantic proximity Read ↗

Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests.Semantic proximity Read ↗

Current State and Future Prospects of Direct-to-Consumer PharmacogeneticsSemantic proximity Read ↗

Statement of the ESHG on direct-to-consumer genetic testing for health-related purposesSemantic proximity Read ↗

23andMe resumes giving consumers genetic health information: Company's tests for rare and common diseases aren't diagnostic.Semantic proximity Read ↗

Pharmacogenomics in the era of next generation sequencing – from byte to bedsideSemantic proximity Read ↗

The regulation of direct-to-consumer genetic tests.Semantic proximity Read ↗

Low-cost generation of clinical-grade, layperson-friendly pharmacogenetic passports using oligonucleotide arrays.Semantic proximity Read ↗

23andMe Paves the Way for Direct-to-Consumer Genetic Health Risk Tests of Limited Clinical Utility.Semantic proximity Read ↗

Pharmacogenetic Testing: Time for Clinical Practice GuidelinesSemantic proximity Read ↗

Direct‐to‐consumer genetic testing: Perspectives on its value in healthcareSemantic proximity Read ↗

Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.